MISSISSIPPI SENATE PASSES "JILL'S LAW," SENDING BIOMARKER TESTING COVERAGE BILL TO GOVERNOR'S DESK
The following information was released by the
The
"In the case of a cancer diagnosis, biomarker testing helps doctors develop a personalized treatment plan so some patients can access targeted treatments and avoid therapies that are unlikely to work for their individual disease. It can help save critical time in a cancer fight," said
The legislation, known as Jill's Law, is named for
"I'm so honored to see such strong, bipartisan support for this important legislation and to have it named in honor of my beloved wife, Jill," Rep.
Cancer survivor
"My provider team knew biomarker testing was the first step we needed to take after my colon cancer diagnosis," Parker said. "Biomarker testing showed us chemotherapy was my best treatment path. It also caught my cancer recurrence. I am here today, nearly seven years after my diagnosis, because of biomarker testing."
The bill now goes to the Governor's desk, where he has the opportunity to sign it and increase access to care for Mississippians.
ACS CAN advocates and volunteers have worked hard this session to support passage of this bill, including at the annual Cancer Action Day at the


MEDICAID FINANCING: THE BASICS
State Farm auto customers getting $100 refund
Advisor News
- Flourish brings private-bank-like cash solution to MassMutual’s network
- Majority of Americans concerned recent market highs are unsustainable
- GLP-1 users choose between medication and retirement saving
- Gen X and millennials seek new retirement model
- Are families ready for the costs of aging at home?
More Advisor NewsAnnuity News
- New class-action lawsuit targets Delaware Life over annuity disclosures
- A client remarried: Does their annuity still fit?
- Gen X and millennials seek new retirement model
- Global Atlantic names Dan Farrelly head of IMO and IBD channels
- A rising retirement challenge: The license to spend
More Annuity NewsHealth/Employee Benefits News
Life Insurance News